Keyword: new therapeutic entity

Plant Construction & Process Technology

Double Risk with an Upgrade

31.10.2013 - Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...